Immunic Inc
(NASDAQ:IMUX)
$1.13
0[0.00%]
Last update: 5:00PM (Delayed 15-Minutes)
Get Real Time Here
$1.13
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open-Close-
Vol / Avg.0 / 777.856KMkt Cap51.014M
Day Range- - -52 Wk Range0.945 - 3.170

Immunic Stock (NASDAQ:IMUX), Quotes and News Summary

Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 777.856KMkt Cap51.014M
Day Range- - -52 Wk Range0.945 - 3.170
Lisa Levin - Oct 10, 2023, 1:08PM
Vandana Singh - Oct 10, 2023, 8:20AM
Lisa Levin - Oct 10, 2023, 8:19AM
Lisa Levin - Apr 5, 2023, 1:33PM
Vandana Singh - Apr 5, 2023, 10:30AM
Lisa Levin - Nov 28, 2022, 8:29AM
Vandana Singh - Nov 17, 2022, 8:04AM
Lisa Levin - Oct 24, 2022, 5:37AM
Vandana Singh - Oct 21, 2022, 3:14PM
Lisa Levin - Oct 21, 2022, 2:33PM
PRNewswire - Nov 21, 2023, 6:30AM
News Direct - Nov 14, 2023, 1:25PM
PRNewswire - Nov 14, 2023, 6:30AM
News Direct - Oct 24, 2023, 7:51AM
PRNewswire - Oct 15, 2023, 6:30AM
PRNewswire - Oct 11, 2023, 6:30AM
News Direct - Oct 11, 2023, 5:15AM
PRNewswire - Oct 10, 2023, 9:31AM
PRNewswire - Oct 9, 2023, 4:01PM
PRNewswire - Oct 4, 2023, 6:30AM
Full archive of press releases available on Benzinga Pro
Seeking Alpha - 6 days ago
InvestorsObserver - Nov 21, 2023, 5:50AM
TipRanks - Nov 14, 2023, 2:40PM
Seeking Alpha - Nov 14, 2023, 10:53AM
Seeking Alpha - Nov 14, 2023, 6:30AM
Seeking Alpha - Nov 13, 2023, 1:12PM
InvestorsObserver - Nov 7, 2023, 5:46AM
InvestorsObserver - Nov 6, 2023, 7:27AM
InvestorsObserver - Nov 3, 2023, 7:14AM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-10-10WedbushAndreas ArgyridesMaintainsOutperformOutperformRaises5.007.00
2023-07-27WedbushAndreas ArgyridesReiteratesOutperformOutperformMaintains-5.00
2023-01-31WedbushAndreas ArgyridesAssumesOutperformAnnounces-5.00
2022-10-21SVB LeerinkThomas SmithDowngradesOutperformMarket PerformLowers9.005.00

Related Companies

TickerCompanyChg %Mkt Cap
IMUXImmunic0%51M
SYRSSyros Pharmaceuticals13.51%61.9M
ESLAEstrella Immunopharma-0.67%52.1M
ACXPAcurx Pharmaceuticals1.67%50.4M
ALGSAligos Therapeutics1.9%53.1M
Q

How do I buy Immunic (IMUX) stock?

A

You can purchase shares of Immunic (NASDAQ: IMUX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immunic's (IMUX) competitors?

A

Other companies in Immunic’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Aligos Therapeutics (NASDAQ:ALGS) and Elicio Therapeutics (NASDAQ:ELTX).

Q

What is the target price for Immunic (IMUX) stock?

A

The latest price target for Immunic (NASDAQ: IMUX) was reported by Wedbush on Tuesday, October 10, 2023. The analyst firm set a price target for 7.00 expecting IMUX to rise to within 12 months (a possible 519.47% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immunic (IMUX)?

A

The stock price for Immunic (NASDAQ: IMUX) is $1.13 last updated November 28, 2023 at 10:00 PM UTC.

Q

Does Immunic (IMUX) pay a dividend?

A

There is no dividend information for Immunic.

Q

When is Immunic (NASDAQ:IMUX) reporting earnings?

A

Immunic’s FY earnings are confirmed for Thursday, February 22, 2024.

Q

Is Immunic (IMUX) going to split?

A

There is no upcoming split for Immunic.

Q

What sector and industry does Immunic (IMUX) operate in?

A

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.